Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Medulloblastoma 1

Interventions

pembrolizumab 86 Cyclophosphamide 58 Carboplatin 57 Specimen Handling 55 fludarabine 46 Nivolumab 45 Magnetic Resonance Spectroscopy 44 Gemcitabine 41 Biopsy 40 Bevacizumab 36 venetoclax 32 Dexamethasone 32 Paclitaxel 29 Cisplatin 29 Pemetrexed 28 Injections 28 Docetaxel 26 atezolizumab 24 Ipilimumab 23 Capecitabine 22 Temozolomide 21 Azacitidine 21 Rituximab 20 Oxaliplatin 20 Cetuximab 20 Lenalidomide 19 Fulvestrant 19 abemaciclib 18 Fluorouracil 17 Vincristine 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Vascular Endothelial Growth Factor A × 90 days × Clear all

NCT07346157 2026-06-01

PNOC044

University of California, San Francisco

Phase 1/2 Not yet recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡